Hong Kong’s Chronic Disease Gap Is a Coordination Problem, Not Just a Capacity One
Hong Kong’s chronic disease burden is large, growing, and structurally under-served by a primary care system that still lacks a mature family doctor network — which is exactly the gap that well-designed patient support programmes are positioned to close.
The scale of the problem, in numbers
Around 31% of Hong Kong’s population — roughly 2.2 million people — reported having a chronic health condition in 2020/21, with 47% of that group aged 65 or older. Hospital Authority projections put the number of patients with chronic diseases at 3 million within the coming decade, and researchers believe the true number of people living with an undiagnosed or unmanaged chronic condition could be as much as double the diagnosed figure. Chronic diseases already account for around 55% of all deaths in Hong Kong.
Why the system is structurally strained
Hong Kong’s primary healthcare system remains underdeveloped relative to comparable economies — the private sector delivers around 70% of all primary care services, and Hong Kong lacks the mature family doctor network that other developed healthcare systems rely on for continuous, coordinated chronic disease management. The imbalance shows up in resource allocation too: public hospitals handle roughly 90% of inpatient cases while accounting for only about two-thirds of total healthcare spending, a structural mismatch that leaves specialist and preventive care under-resourced relative to acute care.
The Hong Kong government’s response — the Primary Healthcare Blueprint, District Health Centres rolling out across all 18 districts, and pilot schemes like the Chronic Disease Co-Care Scheme — is a genuine structural shift toward prevention and community-based chronic disease management. But the same 2025 study on older adults found that even where these services exist, engagement remains low, multidisciplinary care coordination is fragmented, and access, quality, and satisfaction vary along socioeconomic lines. Building the infrastructure is necessary; it isn’t sufficient on its own to close the gap.
What the adherence evidence says about closing that gap
This is where patient support programmes earn their place — not as a nice-to-have add-on to treatment, but as a direct response to a well-documented failure point in chronic disease management. Across chronic conditions generally, research consistently finds that only around half of patients in developed countries adhere to long-term medication regimens, and non-adherence rates for specific therapy classes range from roughly 26% to 63% depending on the condition and treatment complexity.
Text-message reminders roughly double adherence odds
A meta-analysis of 16 randomised controlled trials found that text-message reminders roughly doubled the odds of medication adherence and lifted overall adherence rates by close to 18 percentage points.
Family involvement improves adherence by up to 21%
Programmes that actively involve family members alongside the patient have been associated with adherence improvements of up to 21%.
Nurse-led support can lower total healthcare costs
A published evaluation of a nurse-led patient support programme for a biologic therapy found it increased medication adherence while producing lower total healthcare costs overall, despite higher drug spending — evidence that well-designed support can pay for itself through avoided complications and hospitalisations, not just improve a compliance statistic.
Common questions
Why doesn’t building more clinics alone solve Hong Kong’s chronic disease problem?
Because the evidence points to engagement and coordination, not just access, as the binding constraint. Hong Kong’s District Health Centre rollout is expanding where care is available, but research on older adults using these services already shows low engagement and fragmented multidisciplinary coordination even where centres exist — meaning the technology and programme design that gets patients meaningfully using and staying with care matters as much as building the facility itself.
What actually moves the needle on medication adherence?
The strongest evidence points to a combination of simple, consistent touchpoints (automated reminders roughly double adherence odds in controlled trials) and human relationship — family involvement and nurse-led or case-manager support models show some of the largest documented effects. Technology and human support appear to work best together rather than as substitutes for one another.
Is patient non-adherence mainly a Hong Kong-specific issue?
No — the roughly 50% average adherence rate for long-term chronic disease treatment is consistent across developed healthcare systems globally. What is specific to Hong Kong is the combination of a rapidly ageing population, an underdeveloped family doctor network, and a primary care system still mid-transition — which makes the consequences of that global adherence problem more acute here than in systems with more mature community care infrastructure already in place.
The takeaway
Infrastructure isn’t enough on its own
Hong Kong is building the policy and physical infrastructure for better primary care. The evidence suggests the harder, less visible work is what happens inside that infrastructure — the reminder systems, the care coordination, the case management that turns a chronic disease programme from a service that exists into one that patients actually stay engaged with. That’s a technology and operations problem as much as a clinical one, and it’s where well-designed patient support programmes have the most to contribute.
Sources
- Hong Kong Medical Journal, “Establishment of the Primary Healthcare Commission”
- Legislative Council of Hong Kong, Primary Healthcare Blueprint Brief and LC Paper CB(3)199/2026
- Legislative Council Statistical Highlights, “Health status of Hong Kong citizens” (ISSH11/2024)
- Civic Exchange, “Hong Kong plans wider primary-care network in reform push”
- BMC Primary Care (2025), “Evaluating quality and utilisation of primary care among older adults in Hong Kong”
- Primary Healthcare Commission Office, “The Healthcare Challenges in Hong Kong”
- ScienceDirect, “The role of adherence in patients with chronic diseases”
- PMC, “Patient Support Program Increased Medication Adherence with Lower Total Health Care Costs Despite Increased Drug Spending”
Designing a patient support programme for the Hong Kong market?
We build the reminder systems, care coordination, and case management that turn a programme into one patients actually stay engaged with.
Get in touch →